Aspect Imaging is presenting its advanced line of compact MRIs at WMIC; the simple, one-touch MRIs enable rapid drug testing, saving preclinical researchers time and money

Tel-Aviv, Israel — Aspect Imaging, a life-science company, is presenting its M-series of compact MR imaging systems specialized for pre-clinical research, as well as a brand new integrated simultaneous PET-MRI that combines PET and MRI modalities. In addition, Aspect Imaging is introducing a new Optical and MRI fusion system. The simple-to-use, efficient, and flexible MRI systems that enable rapid in vivo drug efficacy studies will be showcased at the 2016 World Molecular Imaging Congress (WMIC) in New York, booth #214.

The company is introducing a brand new MRI system that combines PET and MRI modalities for simultaneous PET-MRI research. This system is based on the M7 compact MRI, and is the world’s first permanent magnet commercial product for Simultaneous PET/MRI for Preclinical research.

In addition, the company